Burning Rock Biotech Ltd
Research Burning Rock Biotech Ltd (BNR) on Bullrun: market cap USD 70.99M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBNR
- ExchangeNASDAQ
- CountryChina
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Market capUSD 70.99M
- Financial periodFY2025
- RevenueUSD 77.16M
- Net income-USD 7.92M
- Free cash flow-USD 4.82M
- Gross margin74.7%
Valuation Snapshot
latest market cap is USD 70.99M.
About Burning Rock Biotech Ltd
Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services.
Frequently asked questions
What is Burning Rock Biotech Ltd's market cap?
Burning Rock Biotech Ltd's market capitalization is USD 70.99M.
What does Burning Rock Biotech Ltd do?
Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services.